Medicine and Dentistry
Diabetic Retinopathy
81%
Aqueous
55%
Endothelin 1
44%
Proliferative Diabetic Retinopathy
18%
Prospective Study
11%
Inpatient
11%
Pathogenesis
7%
Cataract Surgery
7%
Intravitreal Administration
7%
Eye Disease
3%
Bevacizumab
3%
Aqueous Humor
3%
Injection
3%
Patient
3%
Neuroscience
Diabetic Retinopathy
100%
Endothelin 1
44%
Cataract
7%
Bevacizumab
3%
Ophthalmic Disorder
3%
Vasoconstrictors
3%
Pharmacology, Toxicology and Pharmaceutical Science
Diabetic Retinopathy
81%
Endothelin 1
44%
Proliferative Diabetic Retinopathy
18%
Pathogenesis
7%
Bevacizumab
3%
Eye Disease
3%
Vasoconstrictor Agent
3%
Biochemistry, Genetics and Molecular Biology
Endothelin 1
44%
Bevacizumab
3%
Time
3%
Humor
3%